K2 PRINCIPAL FUND L.P. 13D and 13G filings for Pasithea Therapeutics Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-01-31 6:21 pm Sale |
2021-12-31 | 13G | Pasithea Therapeutics Corp. KTTA |
K2 PRINCIPAL FUND L.P. | 54,721 4.990% |
-30,279 (-35.62%) |
Filing |
| 2021-12-20 4:00 pm Purchase |
2021-11-29 | 13G | Pasithea Therapeutics Corp. KTTA |
K2 PRINCIPAL FUND L.P. | 85,000 7.480% |
85,000 (New Position) |
Filing |